眼科

• 论著 • 上一篇    下一篇

携带MYO7A基因致病突变Usher综合征患者的基因型及临床特征分析

叶汉文 孙腾洋 许可 谢玥 由冰 李杨   

  1. 首都医科大学附属北京同仁医院 北京同仁眼科中心 北京市眼科研究所 眼科学及视觉科学北京市重点实验室 100005
  • 收稿日期:2019-09-17 出版日期:2020-03-25 发布日期:2020-03-25
  • 通讯作者: 李杨,Email:yanglibio@aliyun.com
  • 基金资助:
    国家自然科学基金(81570886)

Genotype and clinical characteristics of Usher syndrome patients with pathogenic mutations in MYO7A gene

Ye Hanwen, Sun Tengyang, Xu Ke, Xie Yue, You Bing, Li Yang   

  1. Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing 100005, China
  • Received:2019-09-17 Online:2020-03-25 Published:2020-03-25
  • Contact: Li Yang, Email: yanglibio@aliyun.com
  • Supported by:
    National Natural Science Foundation of China(81570886)

摘要: 目的 分析中国人携带MYO7A基因致病突变Usher综合征患者的突变特点及临床特征。设计 回顾性病例系列。研究对象 北京同仁医院收集(14例)和其他已报道(19例)携带MYO7A基因致病突变Usher综合征患者33例。方法 患者进行眼科和听力检查,包括最佳矫正视力、眼底像、视网膜相干光断层扫描、闪光视网膜电图、纯音测听、声导抗和畸变耳声发射检查。根据患者临床特征分为Usher综合征Ⅰ型(USH1)和Usher综合征Ⅱ型(USH2)。主要指标 致病基因突变、发病年龄、听力损伤程度。 结果 33例患者中27例为USH1患者,6例为USH2患者。两类患者的听力损伤出现时间分别为USH1(0.8 ±1.8)岁,USH2(2.3±3.2)岁,均早于出现夜盲的时间,USH1(5.4±2.9)岁,USH2(11.8±4.0)岁;但USH1患者听力损伤较USH2患者重。在这些患者中共检出MYO7A基因的44种突变,包括17种错义突变,6种无义突变,12种剪接位点突变,7种框移突变,2种拷贝数变异。USH2患者主要携带错义突变,其比率(9/12,75.0%)明显高于USH1患者(21/54,38.9%)。患者无义突变检出率(12.1%)明显低于文献报告欧洲白种人中无义突变的比例,而剪接位点突变检出率(19.7%)与框移突变检出率(19.7%)高于欧洲白种人。未发现欧美人中的常见突变p.1240R>Q。结论 本研究初步确定了中国人MYO7A基因突变谱,且发现其与欧美人突变谱不同。携带MYO7A基因错义突变Usher综合征患者听力损伤相对较轻。(眼科,2020, 29: 98-103)

关键词: Usher综合征Ⅰ型, Usher综合征Ⅱ型, MYO7A基因

Abstract: Objective To analyze genotype and clinical characteristics of Usher syndrome patients with pathogenic mutations in MYO7A. Design Retrospective case series. Participants 33 Chinese probands (14 from Beijing Tongren Hospital and 19 probands from 10 related literatures) with pathogenic mutations in MYO7A gene. Methods All patients underwent ophthalmic examinations including best-corrected visual acuity, fundus examinations, retinal optical coherence tomography, and flash-electroretinogram, and auditory examinations including pure-tone audiometry, acoustic immittance tests, and otoacoustic emission tests. The patients were classified into Usher syndrome type 1 (USH1) and Usher syndrome type 2 (USH2) according to their clinical characteristics. Main Outcome Measures Mutations in MYO7A gene, age of onset, and degree of hearing impairment. Results Of the 33 probands, 27 probands presented with USH1 and 6 probands presented with USH2. A total of 44 mutations of MYO7A gene were detected in these patients, including 17 missense mutations, 6 nonsense mutations, 12 splicing mutations, 6 frame-shift mutations, and 2 copy number variants. The rate of missense mutations in USH2 patients (9/12, 75.0%) was significantly higher than that in USH1 patients (21/54, 38.9%). The rate of nonsense mutations (12.1%) was significantly lower than that in Caucasians. The rate of splicing mutations (19.7%) and frame-shift mutations (19.7%) was higher than that in Caucasians. The mutation p.1240R>Q that was most common in Caucasians was not found in these patients. Conclusion This study preliminarily confirms the mutation spectrum of MYO7A in Chinese Usher syndrome patients, which differs from that in Caucasians. Usher syndrome patients with missense mutations have milder hearing impairment. (Ophthalmol CHN, 2020, 29: 98-103)

Key words: Usher syndrome typeⅠ, Usher syndrome typeⅡ, MYO7A gene